SENSEX
NIFTY
GOLD
USD/INR

Weather

image 17    C

National News

The Times of India

National / The Times of India

details

Patent rejected for MNCs cancer drug, generics to follow

The Indian Patent Office has rejected AbbVie's patent application for its cancer drug Venetoclax, citing a lack of inventive step and no enhancement in therapeutic efficacy. This decision, if upheld, could allow for the entry of more affordable generic versions of the drug into the Indian market.

23 Jan 2026 4:16 am